跳至主要内容
临床试验/NCT07226310
NCT07226310招募中1 期

The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study: A Randomized Controlled Trial

University of Oklahoma1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
招募中
入组人数
240
试验地点
1
主要终点
Post-HSG Pain Questionnaire

研究概览

简要总结

The hysterosalpingogram (HSG) is the gold standard of assessing fallopian tube patency and involves the placement of a transcervical catheter to allow for instillation of radio-opaque dye into the uterine cavity and fallopian tubes which are then imaged with abdominal x-ray. A common side effect of the instillation of dye is the uterine cramping, which is both uncomfortable for the patient as well as can cause iatrogenic proximal occlusion of the fallopian tubes. Proximal tubal obstruction is often not representative of true tubal obstruction but is rather an artifact of the test. Prior studies measuring the perceived pain and cramping during HSG have been conducted which have shown reduced pain scores and decreased uterine cramping when warmed contrast dye is used. The researchers propose that the use of warmed contrast media during HSG will be correlated with decreased pain scores and fewer cases of proximal tubal occlusion in women with otherwise normal uterine anatomy.

详细描述

Research materials will include obtaining patient past medical history at time of the patient screening and recruitment, via utilization of Epic to search for demographic factors including age, height, weight, BMI, race/ethnicity, duration of infertility, past medical history, and gynecologic/obstetric history.

Post-procedure images from the HSG/report of the HSG findings will be saved in Epic as per usual standard clinical practice. HSG findings will be transcribed with prior demographics/history into a PHI-safe RedCap. No biospecimens will be collected under this protocol.

Patients undergoing fertility treatment that are recommended to undergo HSG as part of their evaluation will be referred to a dedicated research nurse (RN) for eligibility screening and informed consent.

Once found to be meeting inclusion criteria, the patient will be consented and scheduled for HSG as appropriate for their menstrual cycle and clinical care. Typically, patients are scheduled during cycle day 5-10 of their menstrual cycle for best study image quality.

Once scheduled, the patient will be randomized to warmed (body temperature) vs cold (room temperature) HSG. The principal investigator will create a computer-generated randomization table (1:1) using block randomization with randomly varying block size of 4 and 6 without stratification.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

盲法说明

This study will be blinded in a manner that the research nurse, patient, and provider will not be aware of patient allocation at time of recruitment and enrollment. The patient will be assigned a unique study ID number and the randomization module in REDCap will be used to assign the participant to either the experimental (warm) or control (cold) group.

The patient will remain blinded to the treatment allocation but the research nurse and performing provider will be unblinded to allow for correct choice and use of warm versus cold contrast media. As both the research nurse and provider will touch the HSG contrast media and be able to discern if it is cold or warm, it is impossible to maintain blinding of the research team.

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 1. Women ages 18-45 undergoing tubal assessment via HSG.

排除标准

  • History of fibroids
  • History of pelvic inflammatory disease (PID or STD including gonorrhea, chlamydia, or trichomonas)
  • History of surgically diagnosed endometriosis or suspected endometriosis on ultrasound (indicated by visualization of likely endometrioma)
  • History of ectopic pregnancy or 3 or more biochemical pregnancies/pregnancy of unknown location
  • History of tubal or ovarian surgery
  • History of known Mullerian anomaly
  • History of pelvic surgery including appendectomy
  • Allergy to iodine-based contrast media
  • History of prior abnormal fallopian tubes on HSG
  • History of ultrasound with hydrosalpinx (unilateral or bilateral)

研究组 & 干预措施

Cold HSG

No Intervention

HSG contrast will be standard, room-temperature

Warm HSG

Active Comparator

HSG constrast will be warmed.

干预措施: Warmed HSG (Drug)

结局指标

主要结局

Post-HSG Pain Questionnaire

时间窗: Measured 1 hour after HSG procedure

To compare the patient experience for patients undergoing HSG when warm versus cold contrast media is utilized, patients will complete a post-HSG Questionnaire to indicate their level of pain.

次要结局

  • Rate of unilateral and bilateral proximal fallopian tube occlusion(Measured at the time of HSG procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验